U.S. Markets close in 1 hr 50 mins
  • S&P 500

    4,567.42
    +22.52 (+0.50%)
     
  • Dow 30

    35,753.37
    +76.35 (+0.21%)
     
  • Nasdaq

    15,225.79
    +135.59 (+0.90%)
     
  • Russell 2000

    2,311.08
    +19.82 (+0.86%)
     
  • Gold

    1,808.20
    +11.90 (+0.66%)
     
  • EUR/USD

    1.1617
    -0.0028 (-0.2440%)
     
  • 10-Yr Bond

    1.6350
    -0.0200 (-1.21%)
     
  • Vix

    15.25
    -0.18 (-1.17%)
     
  • GBP/USD

    1.3773
    +0.0014 (+0.1005%)
     
  • USD/JPY

    113.6600
    +0.2000 (+0.1763%)
     
  • BTC-USD

    62,962.16
    +2,791.82 (+4.64%)
     
  • CMC Crypto 200

    1,504.00
    +1,261.32 (+519.75%)
     
  • FTSE 100

    7,222.82
    +18.27 (+0.25%)
     
  • Nikkei 225

    28,600.41
    -204.44 (-0.71%)
     

The Tenet Healthcare (NYSE:THC) Share Price Is Up 276% And Shareholders Are Boasting About It

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Tenet Healthcare Corporation (NYSE:THC) share price has soared 276% in the last year. Most would be very happy with that, especially in just one year! Also pleasing for shareholders was the 29% gain in the last three months. And shareholders have also done well over the long term, with an increase of 102% in the last three years.

Check out our latest analysis for Tenet Healthcare

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Tenet Healthcare went from making a loss to reporting a profit, in the last year.

When a company is just on the edge of profitability it can be well worth considering other metrics in order to more precisely gauge growth (and therefore understand share price movements).

Revenue was pretty flat year on year, but maybe a closer look at the data can explain the market optimism.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
earnings-and-revenue-growth

Tenet Healthcare is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. So it makes a lot of sense to check out what analysts think Tenet Healthcare will earn in the future (free analyst consensus estimates)

A Different Perspective

We're pleased to report that Tenet Healthcare shareholders have received a total shareholder return of 276% over one year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 20% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Tenet Healthcare has 4 warning signs (and 2 which don't sit too well with us) we think you should know about.

We will like Tenet Healthcare better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.